CliffBio
small molecule

FENTANYL-100

FENTANYL

Loss of exclusivity—loss of exclusivity
CompanyMayne Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameFENTANYL-100
Active ingredientFENTANYL
Strength100MCG/HR
Dosage formFILM, EXTENDED RELEASE
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalAugust 2007
Marketing statusDISCN

More from Mayne Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.